Wissen Research’s Post

I'm excited to share my recent experience using the new Streamline Viscocanaloplasty System from New World Medical in combination with the iStent Infinite from Glaukos for glaucoma management. This innovative approach has been instrumental in decreasing intraocular pressure (IOP) and reducing the medication burden for our patients. In the procedure, the Streamline system injects viscoelastic into Schlemm's canal, enhancing aqueous outflow. The attached video vividly demonstrates this process, showing viscoelastic and blood refluxing out of an iStent ostium as the viscoelastic is introduced. This visual evidence underscores the efficacy of combining these technologies to improve patient outcomes. Embracing such advancements allows us to offer better care and improve the quality of life for those affected by glaucoma. I'm looking forward to continuing to explore and implement cutting-edge solutions in ophthalmology. #GlaucomaManagement #InterventionalGlaucoma #OphthalmologyInnovation #PatientCare #Glaukos #NewWorldMedical #eyeassociatesofsouthtexas #jtkavanaghmd #streamline #istentinfinite #synergy

Ophthopedia Update:Clinical outcome measures in vision and eye care: Traditionally, clinical outcome assessments have focused on the patient’s perspective through patient-reported outcome assessments; however, given the complexity, integration, and interactions of various participants within the clinical ophthalmology setting, we propose that additional diverse clinical perspectives should be explored in order to fully appreciate the value of care provided to patients. In this review we introduce a framework by which clinical outcome assessments (COAs) can be organized. #Ophthalmology #Eye #Ophthotwitter

📢 𝐎𝐩𝐡𝐭𝐡𝐚𝐥𝐦𝐨𝐥𝐨𝐠𝐲 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐭 𝐟𝐨𝐫 𝐒𝐭𝐫𝐨𝐧𝐠 𝐆𝐫𝐨𝐰𝐭𝐡 𝐛𝐲 2030! The global Ophthalmology Devices Market, valued at USD 54.3 Billion in 2023, is projected to grow to USD 70.8 Billion by 2030, with a CAGR of 5.1%. 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐋𝐢𝐧𝐤 :https://lnkd.in/d7Fq_bKm Ophthalmic devices, critical for diagnosing and treating eye diseases like cataracts and glaucoma, are seeing increased demand due to the rise in eye conditions and the aging population. Technological advancements, including intraocular lenses and minimally invasive surgeries, are boosting market growth. 🌍📈 𝐊𝐞𝐲 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬: ✅ Regional breakdowns: North America leads, driven by advanced medical infrastructure. ✅ Product focus: Vision care devices dominate the market, particularly for cataract surgeries. ✅ End-user segment: Hospitals and eye clinics account for the largest market share. 𝐎𝐩𝐡𝐭𝐡𝐚𝐥𝐦𝐨𝐥𝐨𝐠𝐲 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: 1. Abbott Medical Optics, Inc. 2. Alcon Inc. 3. Appasamy Associates 4. Aurolab 5. Bausch & Lomb Inc. #OphthalmologyDevices #FEMA #Iran #Vance #MaritalRape #BLEACH #HealthcareInnovation #MedicalDevices

We’re gearing up to launch the annual update for our Global Procedure Volumes Database, now fully integrated into our expanded Market Intelligence Software Platform. As part of this launch, let’s take a look at the latest procedure volumes for the United States and Big 5 Europe (France, Germany, Italy, Spain, the UK). Total number of procedures by country: • United States: 89.2M • Germany: 15.0M • France: 12.4M • United Kingdom: 9.3M • Italy: 5M • Spain: 5M Interestingly, the US accounts for nearly 2x the total volume of procedures performed in the largest European markets (82.9M vs. 46.9M). With our customizable forecast-building tool and access to on-demand support from our Medtech analysts, your strategic decisions are backed by the most robust and comprehensive data available. Our database covers over 200 specific procedures across key medical fields, including Aesthetics, Cardio, ENT, General, Neuro, OB/GYN, Ophthalmology, Orthopedic, Peripheral Vascular, Spine, Stereotactic Radiosurgery, and Urological. This comprehensive platform provides historical, current, and forecast data, offering unparalleled insights at global, regional, and country levels. See for yourself why the largest medtech companies, consulting firms, and financial institutions are making the switch - start your free trial today: https://lnkd.in/g8-cdKZ7

The global #MedTech #CMO market is growing at a healthy CAGR of 5%, driven by increased outsourcing and continued MedTech market growth. Find more MedTech CMO Market insights https://lnkd.in/dSzkx4i2 🔍 Market Segmentation: Based on our research, the MedTech CMO market can be segmented into various end-market categories, including: Orthopaedics 🦴 Minimally Invasive Surgery (MIS) 🩺 Cardiovascular 💓 Surgical Instruments 🔧 In Vitro Diagnostics (IVD) 🧬 Other end-market segments 🌐 🏢 Key Players: Prominent companies in the MedTech CMO market include: Jabil Flex Integer Holdings Corporation Tecomet, Inc TE Connectivity Gerresheimer These major players capture less than 25% of the market, highlighting the fragmented nature of the industry. The MedTech CMO market is characterized by a plethora of regional and local small to mid-size companies specializing in niche technologies or markets. 🌍 #MedTech #CMO #MarketGrowth #Healthcare #Orthopaedics #MIS #Cardiovascular #SurgicalInstruments #IVD #Outsourcing #MedicalDevices #MarketInsights #MedTechInnovation #HealthcareIndustry #MedTechTrends #MedicalManufacturing #HealthcareTechnology #GlobalMarket #IndustryAnalysis #TechInHealthcare #HealthcareOutsourcing #MedicalContractManufacturing

We’re gearing up to launch the annual update for our Global Procedure Volumes Database, now fully integrated into our expanded Market Intelligence Software Platform. As part of this launch, let’s take a look at the latest procedure volumes for the United States and Big 5 Europe (France, Germany, Italy, Spain, the UK). Total number of procedures by country: • United States: 89.2M • Germany: 15.0M • France: 12.4M • United Kingdom: 9.3M • Italy: 5.1M • Spain: 5.1M Interestingly, the US accounts for nearly 2x the total volume of procedures performed in the largest European markets (82.9M vs. 46.9M). With our customizable forecast-building tool and access to on-demand support from our Medtech analysts, your strategic decisions are backed by the most robust and comprehensive data available. Our database covers over 200 specific procedures across key medical fields, including Aesthetics, Cardio, ENT, General, Neuro, OB/GYN, Ophthalmology, Orthopedic, Peripheral Vascular, Spine, Stereotactic Radiosurgery, and Urological. This comprehensive platform provides historical, current, and forecast data, offering unparalleled insights at global, regional, and country levels. Start your subscription or learn more here: https://lnkd.in/gQXZHtce

🌟👁️ Discover the clinical advantages of high-dose EYLEA® HD (aflibercept) Injection HCP through the experiences of Drs. Kenneth Fan, Sherveen Salek, and David Brown. In a compelling series of interviews, these experts discuss the effectiveness of this treatment in managing severe retinal diseases, sharing their successes in transforming patient outcomes. Learn more about the potent impact of high-dose Eylea on ophthalmic care. #ASRS2024 #Ophthalmology #MedicalLeadership #VisionaryInOphthalmology #MedicalInnovation #RetinaSpecialists #EyeCareInnovation #VisionScience #MedTech #HealthcareTrends #ClinicalResearch ASRS – American Society of Retina Specialists Bayer Bayer | Ophthalmology

Once a new ophthalmic treatment has demonstrated initial safety, Phase II trials dive deeper. These medium-sized studies continue to assess the therapy's safety and efficacy, while refining the optimal dosage. As an ophthalmology CRO, we leverage our specialized expertise to design these trials, monitor progress, and analyze the results. Our goal is to efficiently generate the data sponsors need to advance their innovations. #ClinicalTrials #PhaseTwoTrial #TrueNorthResearch #Ophthalmology  True North Contract Research Keeley Puls-Boever Travis Holman, MS

The global #MedTech #CMO market is growing at a healthy CAGR of 5%, driven by increased outsourcing and continued MedTech market growth. Find more MedTech CMO Market insights https://lnkd.in/dSzkx4i2 🔍 Market Segmentation: Based on our research, the MedTech CMO market can be segmented into various end-market categories, including: Orthopaedics 🦴 Minimally Invasive Surgery (MIS) 🩺 Cardiovascular 💓 Surgical Instruments 🔧 In Vitro Diagnostics (IVD) 🧬 Other end-market segments 🌐 🏢 Key Players: Prominent companies in the MedTech CMO market include: JabilFlexInteger Holdings CorporationTecomet, IncTE ConnectivityGerresheimer These major players capture less than 25% of the market, highlighting the fragmented nature of the industry. The MedTech CMO market is characterized by a plethora of regional and local small to mid-size companies specializing in niche technologies or markets. 🌍 #MedTech #CMO #MarketGrowth #Healthcare #Orthopaedics #MIS #Cardiovascular #SurgicalInstruments #IVD #Outsourcing #MedicalDevices #MarketInsights #MedTechInnovation #HealthcareIndustry #MedTechTrends #MedicalManufacturing #HealthcareTechnology #GlobalMarket #IndustryAnalysis #TechInHealthcare #HealthcareOutsourcing #MedicalContractManufacturing

Doheny in the News: Last month, SriniVas R Sadda, MD, met with Ophthalmology Times to speak about his study of SB15, looking at the impact of switching patients receiving anti-VEGF therapy to an aflibercept biosimilar, which could be a lower cost and potentially equally effective therapy. Check out the article at this link: https://bit.ly/44HsHHT